Drugs / C2103
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05463497 | Jan → Mar 2022 | — | JW Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C2103 | “C2103: single administration, Tablet, Oral, BID for 5 days” NCT05463497 ↗ |
| Route | Oral | “C2103: single administration, Tablet, Oral, BID for 5 days” NCT05463497 ↗ |